|
Five Doses of COVID-19 Vaccine Recommended for Cancer Patients
|
|
There have been many questions from cancer patients regarding how many COVID-19 vaccines they should receive—and there is finally a conclusive answer. Pharmacists can share the latest guidance from the National Comprehensive Cancer Network, which recommends a three-dose primary mRNA vaccination series followed by two booster doses—for a total of five doses—to be considered up-to-date on immunization. Read more.
|
|
|
Undertreated Hypothyroid Patients Have Worse Hospital Outcomes
|
|
|
Taking the correct amount of thyroid hormone replacement is especially important for patients with hypothyroidism who end up hospitalized, according to a new study in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism. Find out the risks of those patients being undertreated, including longer hospital stays and elevated readmission rates.
|
|
Androgen Suppression Trial for COVID-19 Halted for Futility
|
|
|
While it seemed promising that using androgen-suppressing drugs approved for prostate cancer might also help protect men against severe COVID-19, a trial testing the theory had to be stopped for futility. Even though SARS-CoV-2 entry requires the TMPRSS2 cell-surface protease, temporary androgen suppression induced by degarelix did not improve the clinical outcomes of COVID-19 inpatients. Read more.
|
|
|
Cost of Treating Warts Lowered With Topical Therapies
|
|
Pharmacists do not fill enough prescriptions to treat cutaneous and anogenital warts, according to a new study, which suggests that prescription products might be the most cost-effective treatments. The authors reported that the complaints lead to millions of office visits and average costs per year of about $846 million for cutaneous warts and $127 million for anogenital warts, largely because of lesional destruction procedures. Read more.
|
|
